Stock Events

Stock Events

Prelude Therapeutics (PRLD) Q4 2024 Earnings

Nov 6Confirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.49

-0.47

-0.44

-0.42

Details

Expected EPS

-0.472

Actual EPS

-0.43

Surprise EPS

0.04

Surprise Percent

+8.9%

Description

⁨Prelude Therapeutics⁩ (⁦PRLD⁩) has reported earnings of ⁦-0.43⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.